(Total Views: 754)
Posted On: 06/21/2020 5:17:00 PM
Post# of 154185
iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility™
Wondering again if we’re looking outside the Samsung and AGC Current supply chains to mass produce on another level.
Disclosure, I have 1750 shares of IBIO.
IBIO can ‘Bio React’ monoclonal antibodies.
They ‘Bio React’ not in a big tank line Samsung, but in Tobacco plants in a DARPA funded facility in Texas.
You need more doses? You process more tobacco plants.
Now to be clear, I am not ‘pushing’ IBIO. Don’t care too much about my 1750 shares.
But they can produce 500 Million somethings, doses, vials? At the moment, completely uncorrelated. But 500 million is more than 6 million vials in 2021.
Are there other ideas? I hope. But I add this kind of idea to the discussion, for the good of the order.
Wondering again if we’re looking outside the Samsung and AGC Current supply chains to mass produce on another level.
Disclosure, I have 1750 shares of IBIO.
IBIO can ‘Bio React’ monoclonal antibodies.
They ‘Bio React’ not in a big tank line Samsung, but in Tobacco plants in a DARPA funded facility in Texas.
You need more doses? You process more tobacco plants.
Now to be clear, I am not ‘pushing’ IBIO. Don’t care too much about my 1750 shares.
But they can produce 500 Million somethings, doses, vials? At the moment, completely uncorrelated. But 500 million is more than 6 million vials in 2021.
Are there other ideas? I hope. But I add this kind of idea to the discussion, for the good of the order.
(0)
(0)
